Verastem, Inc. (VSTM)
8.02
+0.41
(+5.39%)
USD |
NASDAQ |
Sep 02, 16:00
7.98
-0.04
(-0.50%)
After-Hours: 20:00
Verastem Net Income (TTM) : -202.70M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -202.70M |
| March 31, 2026 | -193.96M |
| December 31, 2025 | -209.47M |
| September 30, 2025 | -241.10M |
| June 30, 2025 | -166.55M |
| March 31, 2025 | -148.88M |
| December 31, 2024 | -130.64M |
| September 30, 2024 | -93.45M |
| June 30, 2024 | -89.49M |
| March 31, 2024 | -105.52M |
| December 31, 2023 | -87.37M |
| September 30, 2023 | -76.81M |
| June 30, 2023 | -74.89M |
| March 31, 2023 | -72.56M |
| December 31, 2022 | -73.81M |
| September 30, 2022 | -73.48M |
| June 30, 2022 | -78.18M |
| March 31, 2022 | -73.13M |
| December 31, 2021 | -71.20M |
| September 30, 2021 | -74.58M |
| June 30, 2021 | -38.66M |
| March 31, 2021 | -44.77M |
| December 31, 2020 | -67.73M |
| September 30, 2020 | -86.64M |
| June 30, 2020 | -129.91M |
| Date | Value |
|---|---|
| March 31, 2020 | -149.10M |
| December 31, 2019 | -149.21M |
| September 30, 2019 | -121.78M |
| June 30, 2019 | -113.31M |
| March 31, 2019 | -89.49M |
| December 31, 2018 | -72.43M |
| September 30, 2018 | -79.32M |
| June 30, 2018 | -80.78M |
| March 31, 2018 | -75.85M |
| December 31, 2017 | -67.80M |
| September 30, 2017 | -61.22M |
| June 30, 2017 | -46.02M |
| March 31, 2017 | -41.15M |
| December 31, 2016 | -36.44M |
| September 30, 2016 | -36.65M |
| June 30, 2016 | -44.17M |
| March 31, 2016 | -50.98M |
| December 31, 2015 | -57.86M |
| September 30, 2015 | -59.95M |
| June 30, 2015 | -57.84M |
| March 31, 2015 | -55.48M |
| December 31, 2014 | -53.36M |
| September 30, 2014 | -50.74M |
| June 30, 2014 | -48.00M |
| March 31, 2014 | -45.23M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Dianthus Therapeutics, Inc. | -192.25M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |